AVTX
Avalo Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD19.63
+0.34 (+1.76%)
Rating:C
Company Profile
CEO
Garry A. Neil
IPO Date
2015-10-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$19.45
Prev. Close
$19.29
Day Low
$19.32
Day High
$19.84
52W Low
$4.61
52W High
$24.27
Market Cap
$0.22B
Volume
0.08M